Model
Edge
Pharming Group NV
PHAR
Filing Type
20-F
Filing Date
4/3/2024
Updated
4/4/24, 2:03 AM
Filing
20-F
Earnings Release
Exhibits
20-F
Annual and Transition Report of Foreign Private Issuers
EX-1
EX-1.1 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF PHARMING GROUP N.V
EX-1
EX-1.2 BOARD RULES OF PHARMING GROUP N.V.
EX-2
EX-2.1 DESCRIPTION OF SECURITIES
EX-2
EX-2.4 TRUST DEED
EX-4
EX-4.7 ORCHARD
EX-12
EX-12.1 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
EX-12
EX-12.2 CERTIFCATION OF THE PRINCIPAL FINANCIAL OFFICER
EX-13
EX-13.1 CEO
EX-13
EX-13.2 CFO
EX-15
EX-15.1 CONSENT DELOITTE
EX-97
EX-97.1 CLAWBACK POLICY
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC